Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV

Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and variable. To identify the molecular mechanisms responsible for lymphoma killing by CD20 mAb in a homologous system amenable to mechani...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Minard-Colin, Veronique, Xiu, Yan, Poe, Jonathan C., Horikawa, Mayuka, Magro, Cynthia M., Hamaguchi, Yasuhito, Haas, Karen M., Tedder, Thomas F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2008
Assuntos:
Immunobiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515149/
https://ncbi.nlm.nih.gov/pubmed/18495955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-01-135160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados